Evidence map›Paper›PMID 26320186›Full record

ArticleOncotarget2015

Cenp-E inhibitor GSK923295: Novel synthetic route and use as a tool to generate aneuploidy.

Ailsa Bennett, Beatrice Bechi, Anthony Tighe, Sarah Thompson, David J Procter, Stephen S Taylor

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 61 citations in OpenAlex.

  1. Pretreatment Chromosomal Instability Correlates With Radiation Sensitivity in Squamous Cell Cancers.International journal of radiation oncology, biology, physics · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. A survey of chromosomal instability measures across mechanistic models.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. A survey of CIN measures across mechanistic models.bioRxiv : the preprint server for biology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ailsa BennettFaculty of Life Sciences, University of Manchester, United Kingdom.
Beatrice BechiSchool of Chemistry, University of Manchester, United Kingdom.
Anthony TigheFaculty of Life Sciences, University of Manchester, United Kingdom.
Sarah ThompsonFaculty of Life Sciences, University of Manchester, United Kingdom.
David J ProcterSchool of Chemistry, University of Manchester, United Kingdom.
Stephen S TaylorFaculty of Life Sciences, University of Manchester, United Kingdom.
University of Manchester · GB

Funding

Cancer Research UKMedical Research Council MR/L011840/1
6 · The paper itself

Abstract

Aneuploidy is a common feature of cancer, with human solid tumour cells typically harbouring abnormal chromosome complements. The aneuploidy observed in cancer is often caused by a chromosome instability phenotype, resulting in genomic heterogeneity. However, the role aneuploidy and chromosome instability play in tumour evolution and chemotherapy response remains poorly understood. In some contexts, aneuploidy has oncogenic effects, whereas in others it is anti-proliferative and tumour-suppressive. Dissecting fully the role aneuploidy plays in tumourigenesis requires tools and facile assays that allow chromosome missegregation to be induced experimentally in cells that are otherwise diploid and chromosomally stable. Here, we describe a chemical biology approach that induces low-level aneuploidy across a large population of cells. Specifically, cells are first exposed to GSK923295, an inhibitor targeting the mitotic kinesin Cenp-E; while the majority of chromosomes align at the cell's equator, a small number cluster near the spindle poles. By then driving these cells into anaphase using AZ3146, an inhibitor targeting the spindle checkpoint kinase Mps1, the polar chromosomes are missegregated. This results in, on average, two chromosome missegregation events per division, and avoids trapping chromosomes in the spindle midzone, which could otherwise lead to DNA damage. We also describe an efficient route for the synthesis of GSK923295 that employs a novel enzymatic resolution. Together, the approaches described here open up new opportunities for studying cellular responses to aneuploidy.

Indexed as

AneuploidyApoptosisBridged Bicyclo Compounds, HeterocyclicCell Cycle ProteinsCell Line, TumorCell ProliferationChromosomal Proteins, Non-HistoneChromosomesDNA DamageFlow CytometryHCT116 CellsHeLa CellsHumansKinesinsMitosisPhenotypeBridged Bicyclo Compounds, HeterocyclicCell Cycle Proteinscentromere protein EChromosomal Proteins, Non-HistoneGSK923295KinesinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesSarcosineTTK protein, humananeuploidyCenp-Echromosome instabilityChromosome SectionMps1spindle assembly checkpoint

Identifiers

PMID26320186
PMCPMC4673239
OpenAlexW2152602151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.